Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 28581356

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2017 Jul 13
First author
von Minckwitz G

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Jul 13;377(2):186-187. doi: 10.1056/NEJMe1706150.
    note
    Source null
    related pmid
    28581347
    relationship
    Comment in
  2. citation
    N Engl J Med. 2017 Aug 17;377(7):702. doi: 10.1056/NEJMx170011.
    note
    Source null
    related pmid
    28700263
    relationship
    Erratum in
  3. citation
    Nat Rev Clin Oncol. 2017 Dec;14(12):715-716. doi: 10.1038/nrclinonc.2017.125.
    note
    Source null
    related pmid
    28786414
    relationship
    Comment in
  4. citation
    N Engl J Med. 2018 Oct 18;379(16):1585.
    note
    Source null
    related pmid
    30338958
    relationship
    Erratum in

Authors and identifiers

  1. name
    von Minckwitz G
    type
    Author
  2. name
    Procter M
    type
    Author
  3. name
    de Azambuja E
    type
    Author
  4. name
    Zardavas D
    type
    Author
  5. name
    Benyunes M
    type
    Author
  6. name
    Viale G
    type
    Author
  7. name
    Suter T
    type
    Author
  8. name
    Arahmani A
    type
    Author
  9. name
    Rouchet N
    type
    Author
  10. name
    Clark E
    type
    Author
  11. name
    Knott A
    type
    Author
  12. name
    Lang I
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    von Minckwitz G
    type
    Author
  2. name
    Procter M
    type
    Author
  3. name
    de Azambuja E
    type
    Author
  4. name
    Zardavas D
    type
    Author
  5. name
    Benyunes M
    type
    Author
  6. name
    Viale G
    type
    Author
  7. name
    Suter T
    type
    Author
  8. name
    Arahmani A
    type
    Author
  9. name
    Rouchet N
    type
    Author
  10. name
    Clark E
    type
    Author
  11. name
    Knott A
    type
    Author
  12. name
    Lang I
    type
    Author
bibliography ids
  1. nci-bib-a4ed1790e1e2ab1acd39f092
book metadata
content sha256
f75649d1a9d3fcecbdd37e1c7e3cea169d2984afd4cf63d5444d0d03cb6794d1
document type
citation
dois
  1. 10.1056/NEJMoa1703643
electronic publication date
display
2017 Jun 5
precision
day
year
2017
evidence scope
bibliographic_metadata_only
id
pubmed:28581356
immutable id
pubmed:28581356@f75649d1a9d3fcecbdd37e1c7e3cea169d2984afd4cf63d5444d0d03cb6794d1
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
2
name
The New England journal of medicine
nlm unique id
0255562
pages
122-131
volume
377
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2017 Jul 13;377(2):186-187. doi: 10.1056/NEJMe1706150.
    note
    Source null
    related pmid
    28581347
    relationship
    Comment in
  2. citation
    N Engl J Med. 2017 Aug 17;377(7):702. doi: 10.1056/NEJMx170011.
    note
    Source null
    related pmid
    28700263
    relationship
    Erratum in
  3. citation
    Nat Rev Clin Oncol. 2017 Dec;14(12):715-716. doi: 10.1038/nrclinonc.2017.125.
    note
    Source null
    related pmid
    28786414
    relationship
    Comment in
  4. citation
    N Engl J Med. 2018 Oct 18;379(16):1585.
    note
    Source null
    related pmid
    30338958
    relationship
    Erratum in
outcomes validated
false
pmid
28581356
provenance
batch id
1c173f0e18be0c6d461b
provider
NCBI PubMed ESummary
record sha256
5943f126d85860fc23ae7405b9d035c9a78958bb21c3c8786822479ef8bd2229
response sha256
27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
retrieved at
2026-09-09T23:47:25.975513+00:00
publication date
display
2017 Jul 13
precision
day
year
2017
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/28581356/
title
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

Preserved source evidence · Not medical advice